121 related articles for article (PubMed ID: 36657279)
21. Monogenic variants in dystonia: an exome-wide sequencing study.
Zech M; Jech R; Boesch S; Škorvánek M; Weber S; Wagner M; Zhao C; Jochim A; Necpál J; Dincer Y; Vill K; Distelmaier F; Stoklosa M; Krenn M; Grunwald S; Bock-Bierbaum T; Fečíková A; Havránková P; Roth J; Příhodová I; Adamovičová M; Ulmanová O; Bechyně K; Danhofer P; Veselý B; Haň V; Pavelekova P; Gdovinová Z; Mantel T; Meindl T; Sitzberger A; Schröder S; Blaschek A; Roser T; Bonfert MV; Haberlandt E; Plecko B; Leineweber B; Berweck S; Herberhold T; Langguth B; Švantnerová J; Minár M; Ramos-Rivera GA; Wojcik MH; Pajusalu S; Õunap K; Schatz UA; Pölsler L; Milenkovic I; Laccone F; Pilshofer V; Colombo R; Patzer S; Iuso A; Vera J; Troncoso M; Fang F; Prokisch H; Wilbert F; Eckenweiler M; Graf E; Westphal DS; Riedhammer KM; Brunet T; Alhaddad B; Berutti R; Strom TM; Hecht M; Baumann M; Wolf M; Telegrafi A; Person RE; Zamora FM; Henderson LB; Weise D; Musacchio T; Volkmann J; Szuto A; Becker J; Cremer K; Sycha T; Zimprich F; Kraus V; Makowski C; Gonzalez-Alegre P; Bardakjian TM; Ozelius LJ; Vetro A; Guerrini R; Maier E; Borggraefe I; Kuster A; Wortmann SB; Hackenberg A; Steinfeld R; Assmann B; Staufner C; Opladen T; Růžička E; Cohn RD; Dyment D; Chung WK; Engels H; Ceballos-Baumann A; Ploski R; Daumke O; Haslinger B; Mall V; Oexle K; Winkelmann J
Lancet Neurol; 2020 Nov; 19(11):908-918. PubMed ID: 33098801
[TBL] [Abstract][Full Text] [Related]
22. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
Elife; 2014 Oct; 3():. PubMed ID: 25347121
[TBL] [Abstract][Full Text] [Related]
23. Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells.
Song JS; Huh KH; Park J; Ju MK; Kim MS; Kim YS
Transplant Proc; 2008 Mar; 40(2):464-6. PubMed ID: 18374103
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.
Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS
Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139
[TBL] [Abstract][Full Text] [Related]
25. IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex.
Pua KH; Stiles DT; Sowa ME; Verdine GL
Cell Rep; 2017 Jan; 18(2):432-442. PubMed ID: 28076787
[TBL] [Abstract][Full Text] [Related]
26. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.
Liao LX; Song XM; Wang LC; Lv HN; Chen JF; Liu D; Fu G; Zhao MB; Jiang Y; Zeng KW; Tu PF
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5986-E5994. PubMed ID: 28674004
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.
Zou J; Han Z; Zhou L; Cai C; Luo H; Huang Y; Liang Y; He H; Jiang F; Wang C; Zhong W
Med Oncol; 2015 Jan; 32(1):373. PubMed ID: 25465060
[TBL] [Abstract][Full Text] [Related]
31. GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.
Kofuji S; Sasaki AT
J Biochem; 2020 Oct; 168(4):319-328. PubMed ID: 32702086
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil.
Cilião HL; Camargo-Godoy RBO; Souza MF; Zanuto A; Delfino VDA; Cólus IMS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):97-102. PubMed ID: 30442353
[TBL] [Abstract][Full Text] [Related]
33. Inter-ethnic variability of three functional polymorphisms affecting the IMPDH2 gene.
Garat A; Cardenas CL; Lionet A; Devos A; Glowacki F; Kenani A; Migot-Nabias F; Allorge D; Lo-Guidice JM; Broly F; Cauffiez C
Mol Biol Rep; 2011 Nov; 38(8):5185-8. PubMed ID: 21181270
[TBL] [Abstract][Full Text] [Related]
34. The expression and prognostic role of IMPDH2 in ovarian cancer.
Tian Y; Zhang J; Chen L; Zhang X
Ann Diagn Pathol; 2020 Jun; 46():151511. PubMed ID: 32305001
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.
Dammermann W; Polywka S; Dettmann I; Mindorf S; Komorowski L; Wehmeyer M; Schulze Zur Wiesch J; Stöcker W; Lüth S
Med Microbiol Immunol; 2017 Oct; 206(5):379-382. PubMed ID: 28815296
[TBL] [Abstract][Full Text] [Related]
36. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
37. Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer.
Wang W; Wu Y; Chen S; Liu X; He J; Wang S; Lu W; Tang Y; Huang J
Phytother Res; 2021 Jan; 35(1):463-476. PubMed ID: 32779300
[TBL] [Abstract][Full Text] [Related]
38. IMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
Li HX; Meng QP; Liu W; Li YG; Zhang HM; Bao FC; Song LL; Li HJ
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3038-44. PubMed ID: 25392102
[TBL] [Abstract][Full Text] [Related]
39. Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton.
Lake JI; Avetisyan M; Zimmermann AG; Heuckeroth RO
Dev Biol; 2016 Jan; 409(1):152-165. PubMed ID: 26546974
[TBL] [Abstract][Full Text] [Related]
40. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
J Genet Genomics; 2015 Jun; 42(6):287-99. PubMed ID: 26165495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
